Skip to content

 

Delivering Value to Investors

A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome. That mission is behind everything we do, from enabling breakthroughs that move us closer to the realization of precision medicine to delivering value to our investors.

Investor Events
November 1, 2018 | 17:00 ET
Illumina and Pacific Biosciences Conference Call
October 23, 2018 | 17:00 ET
Q3 2018 Illumina Earnings Conference Call
September 13, 2018 | 13:30 ET
Illumina at the Morgan Stanley Annual Global Healthcare Conference
View All Events & Presentations